Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program


Por: Martinez, A, Broner, S, Sala, MR, Manzanares-Laya, S, Godoy, P, Planas, C, Minguell, S, Torner, N, Jane, M, Dominguez, A

Publicada: 1 ene 2015
Resumen:
A hepatitis A+B vaccine vaccination program of 12-year-olds was introduced in Catalonia in 1998. The aim of this study was to investigate the evolution of hepatitis A outbreaks in Catalonia and estimate the preventable fraction of cases associated with outbreaks as a measure of the impact of the vaccination program. Hepatitis A outbreaks reported to the Health Department between 1991 and 2012 were analyzed. The incidence rates of outbreaks, outbreak-associated cases and hospitalizations were calculated. The preventable fraction (PF) and 95% confidence intervals (CI) were estimated for the whole study period (pre-vaccination and post-vaccination) and the post-vaccination period. One-hundred-eight (108) outbreaks (rate of 2.21 per 10(6) persons-year) were reported in the pre-vaccination period and 258 outbreaks (rate of 2.82 per 10(6) persons-year) in the post-vaccination period. The rate of cases associated with outbreaks was 1.52 per 10(5) persons-year in the pre-vaccination period and 1.28 per 10(5) persons-year in the post-vaccination period. Hospitalization rates were 0.08 and 0.75 per 10(6) persons-year, respectively. The number of person-to-person outbreaks whose index case was a school contact decreased in the post-vaccination period (aOR 2.72; 95%CI 1.35-5.48), but outbreaks whose index case was a man who has sex with men (MSM) or an immigrant increased. The PF of all outbreak-associated cases was 6.46% (95%CI 3.11-9.82) and the highest PF was in the 15-24 years age group (42.53%; 95%CI 29.30-55.75). In the 0-4 years age group, the PF was 18.35% (95%CI 9.59-27.11), suggesting a protective herd effect in unvaccinated subjects. Vaccination of immigrants traveling to endemic countries and MSM should be reinforced.

Filiaciones:
Martinez, A:
 Generalitat Catalonia, Publ Hlth Agcy Catalonia, Catalonia, Spain

Broner, S:
 Carlos III Inst Hlth, CIBER Epidemiol & Salud Publ, Madrid, Spain

Sala, MR:
 Generalitat Catalonia, Publ Hlth Agcy Catalonia, Catalonia, Spain

Manzanares-Laya, S:
 Publ Hlth Agcy Barcelona, Barcelona, Spain

Godoy, P:
 Generalitat Catalonia, Publ Hlth Agcy Catalonia, Catalonia, Spain

Planas, C:
 Generalitat Catalonia, Publ Hlth Agcy Catalonia, Catalonia, Spain

Minguell, S:
 Generalitat Catalonia, Publ Hlth Agcy Catalonia, Catalonia, Spain

Torner, N:
 Generalitat Catalonia, Publ Hlth Agcy Catalonia, Catalonia, Spain

 Carlos III Inst Hlth, CIBER Epidemiol & Salud Publ, Madrid, Spain

 Univ Barcelona, Dept Publ Hlth, Barcelona, Spain

Jane, M:
 Generalitat Catalonia, Publ Hlth Agcy Catalonia, Catalonia, Spain

Dominguez, A:
 Carlos III Inst Hlth, CIBER Epidemiol & Salud Publ, Madrid, Spain

 Univ Barcelona, Dept Publ Hlth, Barcelona, Spain
ISSN: 21645515





Human Vaccines & Immunotherapeutics
Editorial
TAYLOR & FRANCIS INC, 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 11 Número: 1
Páginas: 192-197
WOS Id: 000349637500029
ID de PubMed: 25483535
imagen Green Published, Bronze

MÉTRICAS